SeekingAlpha · Jul 2, 2026
InnovAge: A Real Turnaround, But The Stock Now Trades Above Every Analyst Target
InnovAge's turnaround boosts adjusted EBITDA and guidance, but shares hit ATH above targets. Click for more on INNV stock.

NASDAQ · INNV
Healthcare · Medical - Care Facilities
$10.94
Down-$0.16 (-1.44%)
Updated Aug 20, 2026, 5:55 AM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
INNV closed at $10.94 after 21 trading sessions, down 6.34% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 19, 2026 | $11.22 | $11.41 | $10.8038 | $10.94 | 158.04K |
| Aug 18, 2026 | $10.64 | $11.13 | $10.64 | $11.10 | 198.92K |
| Aug 17, 2026 | $10.64 | $10.78 | $10.40 | $10.67 | 175.72K |
| Aug 14, 2026 | $10.63 | $10.80 | $10.51 | $10.61 | 213.5K |
| Aug 13, 2026 | $10.53 | $10.79 | $10.37 | $10.65 | 117.66K |
| Aug 12, 2026 | $10.26 | $10.515 | $10.09 | $10.43 | 144.23K |
| Aug 11, 2026 | $10.91 | $10.915 | $10.20 | $10.23 | 205.86K |
| Aug 10, 2026 | $11.05 | $11.3999 | $10.80 | $10.90 | 214.6K |
| Aug 7, 2026 | $11.04 | $11.22 | $10.76 | $11.18 | 336.37K |
| Aug 6, 2026 | $11.01 | $11.0207 | $10.70 | $10.98 | 146.28K |
| Aug 5, 2026 | $10.89 | $11.175 | $10.73 | $11.09 | 170.54K |
| Aug 4, 2026 | $11.29 | $11.35 | $10.5312 | $10.85 | 285.24K |
| Aug 3, 2026 | $11.41 | $11.87 | $11.18 | $11.23 | 346.96K |
| Jul 31, 2026 | $11.66 | $11.765 | $10.95 | $11.36 | 351.64K |
| Jul 30, 2026 | $11.64 | $11.74 | $11.358 | $11.60 | 150.41K |
| Jul 29, 2026 | $11.72 | $11.89 | $11.44 | $11.47 | 169.52K |
| Jul 28, 2026 | $11.62 | $11.92 | $11.35 | $11.81 | 295.56K |
| Jul 27, 2026 | $11.59 | $11.96 | $11.37 | $11.48 | 236.6K |
| Jul 24, 2026 | $11.30 | $11.7384 | $11.185 | $11.56 | 172.53K |
| Jul 23, 2026 | $11.53 | $11.63 | $10.93 | $11.19 | 224.91K |
| Jul 22, 2026 | $11.78 | $11.8607 | $11.55 | $11.68 | 266.5K |
The latest Smart Investors Daily articles mentioning INNV.
INNV research
Company profile and research snapshot.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 23, 2026 | JP Morgan | Underweight | — |
| Dec 17, 2024 | JP Morgan | Underweight | — |
| Oct 11, 2024 | Keybanc | Sector Weight | — |
| Mar 13, 2024 | JP Morgan | Neutral | — |
| Feb 8, 2024 | Goldman Sachs | Neutral | — |
No generated briefing is available yet.
SeekingAlpha · Jul 2, 2026
InnovAge's turnaround boosts adjusted EBITDA and guidance, but shares hit ATH above targets. Click for more on INNV stock.
Benzinga · Jun 10, 2026
Yahoo · Mar 31, 2026
ACHC rides on strong demand and expansion gains, but premium valuation, rising costs, and weak efficiency raise caution for investors weighing next moves.
Yahoo · Mar 27, 2026
MD expands maternal care in Tennessee through a new partnership, boosts high-risk pregnancy services and aims for immediate earnings accretion.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning INNV.